Stoddard Davenport
MPH
Principal & Healthcare Management Consultant
Denver, CO, US
Stoddard Davenport is a principal and healthcare management consultant with Milliman. He helps lead his practice's behavioral health and public health teams. His expertise is in helping organizations leverage data to advance healthcare delivery, including policy analysis, development and evaluation of healthcare interventions and strategies, and quantification of the impact of important public health issues. He joined the firm in 2011.
Experience
Stoddard's experience includes assisting payers, provider organizations, associations, foundations, and state and federal agencies on a variety of important initiatives:
- Integration of physical and behavioral healthcare
- Research studies on priority populations and policy issues
- Development and evaluation of population health strategies to better allocate resources to patient needs
- Outcomes measurement for healthcare improvement efforts and interventions
- Burden of illness studies, including predictive modeling to identify unmet health needs or underdiagnosed conditions
- Mental health parity compliance reviews
- Behavioral healthcare cost and utilization benchmarks and projections
- Patient attribution and payment reform modeling to support value-based contracting
Stoddard has published extensively on the opioid crisis, mental health parity, and a range of other topics related to public health and behavioral health. Stoddard also leads the development of behavioral health cost and utilization benchmarks for Milliman's Health Cost Guidelines.
Publications and Presentations
- “Access across America: State-by-state insights into the accessibility of care for mental health and substance use disorders.” Milliman Research Report for Inseparable, Inc. December 2023.
- “Approaches for addressing nonmedical health drivers through Medicaid managed care.” Milliman Research Report for the Episcopal Health Foundation. February 2023.
- “Behavioral healthcare utilization changes during the COVID-19 pandemic.” Milliman research report for Well Being Trust. March 2021.
- “How do individuals with behavioral health conditions contribute to physical and total healthcare spending?” Milliman research report for the Mental Health Treatment and Research Institute LLC, a not-for-profit subsidiary of The Bowman Family Foundation. August 2020.
- “Household dynamics in the prevalence of mental health conditions and substance use disorders.” Milliman White Paper. January 2020.
- “Addiction and mental health vs. physical health: widening disparities in network use and provider reimbursement.” Milliman research report for the Mental Health Treatment and Research Institute LLC, a not-for-profit subsidiary of The Bowman Family Foundation. November 2019.
- “Economic impact of non-medical opioid use in the United States.” Milliman research report for the Society of Actuaries. October 2019.
- “Potential Economic Impact of Integrated Medical-Behavioral Healthcare: Updated projections for 2017.” Milliman White Paper. February 2018.
- “Population Health in Primary Care: Cost, Quality, and Experience Impact.” The American Journal of Accountable Care, September 2017.
- “Cost of Community Violence to Hospitals and Health Systems.” Milliman research report for the American Hospital Association. July 2017.
Education
- MPH, Dartmouth College
- BA (Summa Cum Laude), Economics, Boise State University
Publications
Read their latest work
Article
Access across America: State-by-state insights into the accessibility of care for mental health and substance use disorders
13 December 2023 - by Stoddard Davenport, Bridget Darby, Travis Gray, Cole Spear
Understanding behavioral healthcare access the United States is crucial for developing and implementing effective policies and interventions.
Article
Approaches for addressing nonmedical health drivers through Medicaid managed care
16 February 2023 - by Stoddard Davenport, Matt Caverly, Darin Muse
Via a landscape study and actuarial analysis in Texas, we examine approaches for addressing nonmedical health drivers through Medicaid managed care.
Article
ACO REACH: Leveraging data to reach the underserved and address disparities
15 December 2022 - by Molly Bilz, Stoddard Davenport, Brent Jensen, Chris Lewis, Shelley Moss, Matthew Smith, Jill Van Den Bos
Now that CMS requires REACH ACOs to measure and address health equity, providers face a steep learning curve with data analysis.
Article
Peer review of OnTrak program savings reconciliation methodology
09 April 2021 - by Stoddard Davenport, Doug Norris
Behavioral health program’s methodology used to calculate health care savings measures up to peer review
Article
How the Consolidated Appropriations Act of 2021 affects MHPAEA
25 February 2021 - by Stephen P. Melek, Stoddard Davenport
How the Consolidated Appropriations Act of 2021 affects MHPAEA.
Article
Critical Point Episode 28: How has the COVID-19 pandemic affected mental health in America?
12 January 2021 - by Stoddard Davenport
The COVID-19 pandemic has spurred—and aggravated—a range of mental health and substance use issues in the United States, and Milliman’s Stoddard Davenport discusses recent statistics on the topic and what the road ahead may look like for mental health in America.
Article
The emerging need for telehealth approaches for the treatment of mental illnesses and substance use disorders during the COVID-19 pandemic
24 September 2020 - by Stephen P. Melek, Stoddard Davenport, Travis Gray
Telehealth visits may become part of the new “normal” for replacing, or at least supplementing, office visit-based treatment for behavioral health conditions.
Article
How do individuals with behavioral health conditions contribute to physical and total healthcare spending?
13 August 2020 - by Stoddard Davenport, Travis Gray, Stephen P. Melek
This report examines in detail the characteristics of total healthcare costs for all patients, and separately for high-cost patients, with a focus on the role played by behavioral health conditions and treatment.
Article
Economic costs of the opioid crisis for employers
03 August 2020 - by Stoddard Davenport, Matt Caverly, Katie Matthews
The economic costs (both direct and indirect) of nonmedical opioid use are substantial to U.S. employers, not only due to lost productivity, but also due to increased healthcare expenditures, greater costs for workers’ compensation and disability claims, and difficulty meeting recruitment or production targets in regions that experience shortages of workers.
Article
Everything you think you know about COVID-19 is probably wrong, but some of it is useful
10 June 2020 - by Pamela M. Pelizzari, Stoddard Davenport, Carol Bazell
What are the challenges of interpreting data, reports, and media coverage surrounding the COVID-19 pandemic?